piracetam

网络  吡拉西坦; 脑复康; 西坦; 吡乙酰胺

化学



双语例句

  1. Conclusion The breviscapine injection and piracetam could be combined use directly without diaspense abstinence.
    结论灯盏花素注射液与吡拉西坦注射液可以直接配伍使用。
  2. Effects of Piracetam on Cognitive Functions and Serum Antiepileptic Drugs Concentration in Epileptic Children
    吡拉西坦对癫痫儿童认知功能及抗癫痫药物血药浓度的影响
  3. Effects of Piracetam on Superoxide Dismutase Activity and Malonaldehyde Content in Brain Tissues of D-galactose-induced Aging Rats
    吡拉西坦对D-半乳糖致衰老模型大鼠脑组织超氧化物歧化酶活性和丙二醛含量的影响
  4. OBJECTIVE: To observe the therapeutic effects of aniracetam and piracetam in 66 hypomnesis patients in single blind randomly way.
    目的:对记忆力减退患者66例进行茴拉西坦(阿尼西坦)、吡拉西坦随机单盲阳性药物对照治疗并对疗效进行观察。
  5. Methods Totally 60 patients with mild or medium brain injury were randomly assigned to receive oxiracetam or piracetam as control. MMSE and WMS scales were used to evaluate the therapeutic effects.
    方法将60例轻中型脑伤患者随机分入奥拉西坦治疗组(30例)与吡拉西坦对照组(30例)进行治疗,通过MMSE量表、WMS量表对两组疗效进行评价。
  6. AIM: To compare the clinical efficacy and adverse reaction of citicoline capsules and piracetam tablets in treating cerebral infarction.
    目的:比较胞磷胆碱钠胶囊和吡拉西坦片治疗脑梗死的疗效和不良反应。
  7. Objective To observe the effect of piracetam on intracranial pressure ( ICP).
    目的观察脑复康对颅内压的影响。
  8. AIM: To observe the effect of choline+ piracetam to treat age associated memory impairment ( AAMI).
    目的:观察复方吡拉西坦对增龄相关记忆障碍的疗效。
  9. AIM: To compare the therapeutic effects of nicergoline and piracetam on vascular dementia.
    目的:比较尼麦角林与吡拉西坦对血管性痴呆的疗效。
  10. Piracetam compound vs placebo in treating Alzheimer's disease
    对比复方吡拉西坦与安慰剂治疗阿耳茨海默病
  11. A total of 48 consecutive patients with either mild or moderate brain injury was randomly assigned to either oxiracetam group or piracetam group with 24 cases in each group.
    将连续收治的48例轻中型脑损伤患者随机分入奥拉西坦组和吡拉西坦组,每组24例。
  12. Piracetam tablets were determined by HPLC using phenacetin as internal standard.
    以非那西丁为内标,采用HPLC法测定吡拉西坦(脑复康)片的含量。
  13. Citicoline capsules vs piracetam tablets in treatment of cerebral infarction
    胞磷胆碱钠胶囊和吡拉西坦片治疗脑梗死比较
  14. Effect of Piracetam on Intracranial Pressure in Dogs
    脑复康对麻醉犬颅内压的影响
  15. The pharmacokinetics of piracetam in rats is of the linear pharmacokinetic characteristic.
    吡拉西坦的大鼠体内药物动力学具有线性药物动力学特征。
  16. Influence of the piracetam open-field activity and behavioral reaction in rats
    脑复康对大鼠在开阔场地上活动和行为反应的影响
  17. CONCLUSION: Citicoline capsules are superior to piracetam tablet in treating cerebral infarction.
    结论:胞磷胆碱钠胶囊是一个安全有效的治疗脑梗死药物,疗效优于吡拉西坦片。
  18. Effects of Piracetam on Shuttling Behavior and Brain Metabolism in Rats
    大鼠微灌注脑复康对穿梭行为及脑代谢的影响
  19. Effects of Piracetam on Cerebral Edema and Change in Neurological Function Induced by Cerebral Ischemia in Rats
    脑复康对大鼠局灶性脑缺血引起的脑水肿及神经功能变化的影响
  20. CONCLUSION: MQ, HDS and ADL of patients with Alzheimer's disease were improved by piracetam compound, without severe side effects.
    结论:复方吡拉西坦能明显提高Alzheimer病人的记忆,认知和生活能力,无严重副作用。
  21. Galantamine vs piracetam in treatment of senile dementia and benign senescent forgetfulness
    加兰他敏与吡拉西坦治疗老年性痴呆和良性衰老性遗忘症的比较
  22. OBJECTIVE: To establish a RP-HPLC method for the determination of piracetam for injection and its related substances.
    目的建立了RP-HPLC方法测定注射用吡拉西坦含量及有关物质。
  23. Methods 30 patients which treated with UBI were randomly divided into treated group, and 27 patients which were treated with Piracetam into control group.
    方法采用UBI治疗老年血管性痴呆30例,同时以脑复康治疗27例作为对照组。
  24. AIM: To confirm the effect of piracetam compound ( PC) on Alzheimer's disease.
    目的:观察复方吡拉西坦治疗Alzheimer病的疗效。
  25. Biopterin contents in caudate, nucleus and brain stem were specially reduced by 20mg/ g Piracetam.
    20mg/g组在尾核、小脑和脑干的生物蝶呤含量显著降低。
  26. The efficacy of aniracetam and piracetam in treatment of brain injury induced memory decreasing
    阿尼西坦和脑复康治疗脑外伤后记忆减退
  27. Acupuncture group received the treatment of head and body acupuncture points, and the control group treated with western medicine piracetam.
    其中针刺组采用头体针配穴法治疗;而对照组采用西药脑复康治疗。
  28. Through the spleen and kidney deficiency type mild cognitive impairment Clinical Observation and Piracetam Capsule ( piracetam) in control, to explore the mechanism of its efficacy for the drug lay the foundation for clinical application. Ways: 1.
    通过对脾肾两虚型轻度认知障碍的临床疗效观察,并与脑复康胶囊(吡拉西坦)对照,以探讨其疗效机理,为该药临床推广应用打下基础。